Optimizing strategies for Chlamydia trachomatis and Neisseriagonorrhoeae screening in men who have sex with men: a modelling study.
International guidelines recommend the systematic screening of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) infections in all men who have sex with men (MSM) engaged in unprotected sex. However, the optimal screening strategy remains unclear. We developed a modeling approach to optimize NG/CT screening strategy in MSM. A compartmental model of NG/CT screening and infection was implemented. NG/CT anal (A), pharyngeal (P) and urine (U) samples from MSM attending the STI clinic were used to estimate the screening rate, prevalence, and incidence in a base case scenario. Different screening strategies were then evaluated: APU samples /12 months (S1), APU samples /3 months (S2), APU samples /6 months (S3), AP samples /6 months (S4), AP samples/3 months (S5). 2973 triplet APU samples from 1255 patients were analyzed. 485 NG and 379 CT diagnoses were observed. NG/CT prevalence and incidence estimates were 12.0%/11.1% and 40/100PY / 29/100PY respectively in the base case scenario. As compared to the S2 reference strategy, the proportion of missed NG/CT diagnoses was 42.0%/41.2% with S1, 21.8%/22.5% with S3, 25.6%/28.3% with S4 and 6.3%/10.5% withS5 strategy respectively. . As compared to S2 strategy, S1 reduced the cost of analysis by 74%, S3 by 50%, S4 by 66% and S5 by 33% respectively. The number needed to screen for catching up the missed NG/CT diagnoses was 49/67 with S1, 62/82 with S3, 71/87 with S4 and 143/118 with S5 strategy respectively. S5 appears to be the best strategy, missing only 6.3%/10.5% of NG/CT diagnoses for a cost reduction of 33%.